LINDSAY STEVENS: Open Payments
NPI 1083277362 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 108 payments from 13 companies in 2025. Trend: 2023 $1,505 · 2024 $2,001 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 26 | $422 |
| ABBVIE INC. | 26 | $272 |
| Janssen Biotech, Inc. | 18 | $263 |
| Novartis Pharmaceuticals Corporation | 15 | $194 |
| Galderma Laboratories, L.P. | 8 | $154 |
| GENZYME CORPORATION | 4 | $78 |
| Lilly USA, LLC | 3 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
| Organon LLC | 2 | $32 |
| Amgen Inc. | 1 | $21 |
Products named: Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, DUPIXENT, TALTZ, VTAMA.
Industry payments across IN — which companies pay providers there.
